Compare Beyond Meat Inc (BYND) vs CVS Health Corp (CVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Beyond Meat Inc vs CVS Health Corp — how do they compare? Beyond Meat Inc trades at $0.43 (market cap $268.23M), while CVS Health Corp trades at $93.7 (market cap $122.36B). The key difference: CVS Health Corp is far larger — about 456.2× Beyond Meat Inc's market cap, and CVS Health Corp pays a 2.78% dividend while Beyond Meat Inc pays none. Which is the better fit depends on your goals.
| BYND | CVS | |
|---|---|---|
Market Cap | $268.23M | $122.36B |
Sector | Consumer Staples | Health |
52-Week High | $3.62 | $110.60 |
52-Week Low | $0.42 | $65.51 |
Enterprise Value | $508.51M | $184.71B |
Dividend Yield | — | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BYND trades at $0.5377, up 1.93% today, but remains in a deep bearish technical trend with weak sentiment. The company reported a surprising net income of $178M in 2025 after years of losses, though revenue continues to decline. Recent Q2 2026 earnings showed a smaller loss than expected, with management focusing on international expansion and new product launches like Beyond Steak Filet to drive a turnaround.
The outlook remains challenging with declining revenue, negative operating cash flow, and heavy reliance on financing. Analyst consensus is overwhelmingly bearish with 57% sell ratings. Key risks include execution of the turnaround strategy, intense competition, and persistent cash burn. The stock presents high risk with potential reward contingent on successful business transformation.
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Beyond Meat Inc
Beyond Meat is a provider of plant-based meats, such as burgers, sausage, ground beef, and chicken. Unlike other vegetarian products, Beyond Meat seeks to replicate the look, cook, and taste of meat, is targeted to omnivores and vegetarians alike, and is sold in the meat case. The products are widely available across the U.S. and Canada and in 83 additional countries as well. International revenue represented 31% of 2021 sales. The firm's products are available in retail stores and the food-service channel. In 2019, before the pandemic struck, sales were evenly split between these two channels, although mix stood at 70% retail/30% food service in 2021. We think the recovery from the crisis and new deals with McDonald's and Yum Brands will return food-service sales to nearly 50% in time.
Read more on BYND →About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →
